Injectable Microparticles of Bioceramic for Bone Reconstruction Animal and Human Applications. HYDROS™ Concept

Abstract:

Article Preview

A new biphasic calcium phosphate ceramic material Hydros™ has been developed. The main attractive feature of BCP ceramic is their ability to form a strong direct bond with the host bone resulting in a strong interface. Currently, granules are more and more used in moldable, injectable bone substitutes. However, the biological behaviour of the particles can be influenced not only by chemical composition and crystallinity, but also by several parameters as microporosity and nano-micro sized particles. The aim of the study was to assess, in animal experiment, the role played by an Hydrated Putty Bioceramics (Hydros™), based on specific combination of hydrophilic micro and macrosized BCP particles, to obtain high osteogenic Injectable Bone Substitute. No sign of clinical rejection was noticed. In muscular area, no fibrous encapsulation was observed, degradation of the smaller particles is observed by macrophages and giant cells. At 12 weeks, more of 75% of BCP was resorbed. The biocompatibility and safety in human orthopaedic applications (tibial plateau fracture) has been demonstrated.

Info:

Periodical:

Key Engineering Materials (Volumes 493-494)

Main Theme:

Edited by:

Eyup Sabri Kayali, Gültekin Göller and Ipek Akin

Pages:

714-717

Citation:

G. Daculsi et al., "Injectable Microparticles of Bioceramic for Bone Reconstruction Animal and Human Applications. HYDROS™ Concept", Key Engineering Materials, Vols. 493-494, pp. 714-717, 2012

Online since:

October 2011

Export:

Price:

$41.00

[1] D.C. Moore, M.W. Chapman, D. Manske, (1987)J Orthop Res 5 356-365.

[2] G. Daculsi, N. Passuti, S. Martin, C. Deudon, R.Z. (1990) Legeros, S. Raher, J Biomed Mater Res 24 379-396.

DOI: https://doi.org/10.1002/jbm.820240309

[3] N. Passuti, G. Daculsi, [Calcium phosphate ceramics in orthopedic surgery], (1989) Presse Med 18 28-31.

[4] G. Grimandi, P. Weiss, F. Millot, G. Daculsi, (1998) J Biomed Mater Res 39 660-666.

[5] H. Gautier, J. Guicheux, G. Grimandi, A. Faivre-Chauvet, G. Daculsi, C. Merle, (1998) J Biomed Mater Res 40 606-613.

DOI: https://doi.org/10.1002/(sici)1097-4636(19980615)40:4<606::aid-jbm12>3.0.co;2-d

[6] B.H. Fellah, N. Josselin, D. Chappard, P. Weiss, P. Layrolle, (2007) J Mater Sci Mater Med 18 287-294.

[7] O. Malard, J.M. Bouler, J. Guicheux, D. Heymann, P. Pilet, C. Coquard, G. Daculsi, (1999) J Biomed Mater Res 46 103-111.

DOI: https://doi.org/10.1002/(sici)1097-4636(199907)46:1<103::aid-jbm12>3.0.co;2-z

[8] G. Daculsi, R.Z. LeGeros, M. Heughebaert, I. Barbieux, (1990) Calcif Tissue Int 46 20-27.

DOI: https://doi.org/10.1007/bf02555820

[9] K. Hatano, H. Inoue, T. Kojo, T. Matsunaga, T. Tsujisawa, C. Uchiyama, Y. Uchida, (1999) Bone 25 439-445.

[10] S.J. Lee, J.S. Choi, K.S. Park, G. Khang, Y.M. Lee, H.B. Lee, (2004)Biomaterials 25 4699-4707.

[11] N. Passuti, G. Daculsi, J.M. Rogez, S. Martin, J.V. Bainvel, (1989)Clin Orthop Relat Res 169-176.